EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹971 Cr | ₹727 Cr | ₹747 Cr | ₹973 Cr | ₹657 Cr |
| Adjustment | ₹552 Cr | ₹543 Cr | ₹492 Cr | ₹399 Cr | ₹582 Cr |
| Changes In working Capital | ₹-424 Cr | ₹51 Cr | ₹-292 Cr | ₹-292 Cr | ₹-335 Cr |
| Cash Flow after changes in Working Capital | ₹1,099 Cr | ₹1,321 Cr | ₹947 Cr | ₹1,079 Cr | ₹905 Cr |
| Cash Flow from Operating Activities | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr |
| Cash Flow from Investing Activities | ₹-94 Cr | ₹-713 Cr | ₹-468 Cr | ₹-789 Cr | ₹-252 Cr |
| Cash Flow from Financing Activities | ₹-814 Cr | ₹-164 Cr | ₹-145 Cr | ₹-152 Cr | ₹-189 Cr |
| Net Cash Inflow / Outflow | ₹-56 Cr | ₹221 Cr | ₹134 Cr | ₹-172 Cr | ₹264 Cr |
| Opening Cash & Cash Equivalents | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr | ₹-609 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | ₹214 Cr | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹-2.05 Cr | ₹-2.00 Cr | ₹-0.13 Cr | ₹0.19 Cr | ₹-4.62 Cr |
| Closing Cash & Cash Equivalent | ₹-14 Cr | ₹44 Cr | ₹-175 Cr | ₹-308 Cr | ₹-350 Cr |
Compare Cashflow Statement of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹35,694.9 Cr | 1.1% | 2.4% | 36.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 1.1% |
2.4% |
36.1% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses